Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
129.45
+0.74 (+0.57%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
67
68
Next >
Why Are IO Biotech Shares Trading Lower Today
June 14, 2023
IO Biotech (NASDAQ: IOBT) randomized 225 patients in its global Phase 3 clinical trial for IO102-IO103, in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) in
Via
Benzinga
2 Healthcare Stocks That Could Make You Richer
June 14, 2023
Both companies are proven innovators.
Via
The Motley Fool
Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development
June 14, 2023
Eli Lilly And Co (NYSE: LLY) CEO David Ricks voiced his concerns about the potential impact of Medicare price negotiations on drug development, which aim to reduce costs for older Americans.
Via
Benzinga
Merck Enters The Ring In Weight Loss — But Novo, Lilly Could Be The Winners
June 13, 2023
This update in nonalcoholic steatohepatitis helps prove the benefit of GLP-1 in the liver disease.
Via
Investor's Business Daily
Negotiation or Coercion? Big Pharma and US Chamber of Commerce Tackle Government on Drug Prices
June 12, 2023
The U.S. Chamber of Commerce has filed a lawsuit against the federal government, challenging a recent law that grants Medicare the authority to negotiate drug prices with pharmaceutical companies.
Via
Benzinga
This Is What Whales Are Betting On Merck & Co
June 07, 2023
Via
Benzinga
Analyst Ratings for Merck & Co
May 30, 2023
Via
Benzinga
Why PDS Biotech Shares Are Jumping Today
May 26, 2023
Via
Benzinga
This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street
June 12, 2023
A big turnaround could be in the cards for this medical device maker.
Via
The Motley Fool
Week In Review: Shanghai HighTide Therapeutics Files For Hong Kong IPO
June 10, 2023
HighTide Therapeutics filed for an IPO on the Hong Kong Exchange. Additionally, Shanghai Fosun Pharma will partner with the International Finance Corp to build a pharmaceutical production facility and...
Via
Talk Markets
Does Moderna's Cancer Breakthrough Make It a Good Stock to Buy Now?
June 10, 2023
Cancer vaccines have been around a long time, but they usually don't produce such compelling results.
Via
The Motley Fool
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
June 08, 2023
Today's big decliner could become tomorrow's market winner.
Via
The Motley Fool
The 3 Best Defensive Stocks to Buy in June 2023
June 07, 2023
With market and economic concerns rising, investors may find comfort targeting these ideas for the best defensive stocks to buy.
Via
InvestorPlace
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It 'Extortion'
June 06, 2023
Merck & Co Inc (NYSE: MRK) has reportedly filed a lawsuit against the U.S. government to halt implementing the Medicare drug price negotiation program outlined in the Inflation Reduction Act (IRA).
Via
Benzinga
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
June 06, 2023
Via
Benzinga
Merck Delivers First Legal Blow To Biden's Medicare Negotiation Plan, Calling It A 'Sham'
June 06, 2023
The company hopes to block elements of the Inflation Reduction Act focused on the prices Medicare pays for drugs.
Via
Investor's Business Daily
Moderna and Merck Report Significant Success in Investigational Skin Cancer Therapy, Cuts Risk Of Distant Metastasis Or Death By 65%
June 05, 2023
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment
June 02, 2023
BioNTech is testing out a next-generation form of Yervoy, hoping to reduce side effects.
Via
Investor's Business Daily
3 Undervalued Dow Stocks to Buy Before Wall Street Does
June 02, 2023
The Street is down on the blue-chip index, but these undervalued Dow Jones stocks should generate big profits for long-term investors.
Via
InvestorPlace
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
June 01, 2023
On CNBC’s "Halftime Report Final Trades," Anastasia Amoroso of JPMorgan Private Bank named iShares 7-10 Year Treasury Bond ETF (NASDAQ: IEF)
Via
Benzinga
7 Dividend Stocks to Buy (and Never Sell)
May 31, 2023
Each representing high-quality at reasonable prices, consider each of these seven some of the best long-term dividend stocks to buy.
Via
InvestorPlace
3 Innovative Growth Stocks to Buy for Next-Gen Profits
May 31, 2023
These are the innovative growth stocks for future profits as they represent companies investing significantly in research and development.
Via
InvestorPlace
Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
May 30, 2023
A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers.
Via
Talk Markets
Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap — Who Could Be Next To Join Elusive Club?
May 30, 2023
A surge in price for shares of Nvidia Corporation (NASDAQ: NVDA) after the company’s quarterly earnings results and guidance has put the semiconductor company in the elusive $1 trillion market...
Via
Benzinga
Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years
May 28, 2023
These two pharmaceutical companies have created value for shareholders.
Via
The Motley Fool
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
May 26, 2023
Roche tested its treatment in patients with liver cancer and found "meaningful" results.
Via
Investor's Business Daily
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
May 26, 2023
Benzinga
Via
Benzinga
AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer
May 26, 2023
Via
Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
May 26, 2023
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
67
68
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.